Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-04 01:29 | 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $49.34 | 7,500 | $370,076 | 97,994 | -7.1% |
| 2026-03-04 05:32 | 2026-03-03 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $40.65 | 2,500 | $101,620 | 97,994 | -2.5% |
| 2025-09-04 01:53 | 2025-09-02 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $16.26 | 18,428 | $299,639 | 97,994 | -15.8% |
| 2024-09-05 23:04 | 2024-09-03 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $28.17 | 18,531 | $522,074 | 116,422 | -13.7% |
| 2023-03-09 00:29 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $15.26 | 291 | $4,442 | 59,115 | -0.5% |
| 2023-03-03 03:05 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $15.90 | 1,850 | $29,421 | 38,406 | -4.6% |
| 2022-03-08 04:49 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $16.85 | 303 | $5,104 | 35,256 | -0.9% |
| 2022-03-04 00:17 | 2022-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $17.75 | 420 | $7,456 | 22,259 | -1.9% |
| 2021-12-29 01:00 | 2021-12-27 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $20.07 | 12,560 | $252,139 | 22,679 | -35.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.